Comparing two weight-loss medications for obesity and metabolic health

This trial compares two medications—tirzepatide and semaglutide—to see how they differently affect weight loss and metabolic health in people with obesity and metabolic syndrome. Both medications are injected weekly and help reduce appetite and weight. The study will measure not just how much weight you lose, but also where the fat comes from (like around organs) and how your heart health improves.

These medications work in similar but slightly different ways in the body. Researchers want to understand whether one medication may be better at removing dangerous fat from around the liver and organs, or producing other health benefits that the other doesn't. This information could help doctors choose the best treatment for each patient.